Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 11(2): e0149621, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26919047

RESUMEN

High-throughput experimental methods such as medical sequencing and genome-wide association studies (GWAS) identify increasingly large numbers of potential relations between genetic variants and diseases. Both biological complexity (millions of potential gene-disease associations) and the accelerating rate of data production necessitate computational approaches to prioritize and rationalize potential gene-disease relations. Here, we use concept profile technology to expose from the biomedical literature both explicitly stated gene-disease relations (the explicitome) and a much larger set of implied gene-disease associations (the implicitome). Implicit relations are largely unknown to, or are even unintended by the original authors, but they vastly extend the reach of existing biomedical knowledge for identification and interpretation of gene-disease associations. The implicitome can be used in conjunction with experimental data resources to rationalize both known and novel associations. We demonstrate the usefulness of the implicitome by rationalizing known and novel gene-disease associations, including those from GWAS. To facilitate the re-use of implicit gene-disease associations, we publish our data in compliance with FAIR Data Publishing recommendations [https://www.force11.org/group/fairgroup] using nanopublications. An online tool (http://knowledge.bio) is available to explore established and potential gene-disease associations in the context of other biomedical relations.


Asunto(s)
Biología Computacional/métodos , Bases de Datos Genéticas , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Humanos
2.
Nat Genet ; 47(2): 115-25, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25581432

RESUMEN

Many cancer-associated somatic copy number alterations (SCNAs) are known. Currently, one of the challenges is to identify the molecular downstream effects of these variants. Although several SCNAs are known to change gene expression levels, it is not clear whether each individual SCNA affects gene expression. We reanalyzed 77,840 expression profiles and observed a limited set of 'transcriptional components' that describe well-known biology, explain the vast majority of variation in gene expression and enable us to predict the biological function of genes. On correcting expression profiles for these components, we observed that the residual expression levels (in 'functional genomic mRNA' profiling) correlated strongly with copy number. DNA copy number correlated positively with expression levels for 99% of all abundantly expressed human genes, indicating global gene dosage sensitivity. By applying this method to 16,172 patient-derived tumor samples, we replicated many loci with aberrant copy numbers and identified recurrently disrupted genes in genomically unstable cancers.


Asunto(s)
Variaciones en el Número de Copia de ADN , Dosificación de Gen , Regulación Neoplásica de la Expresión Génica/genética , Genómica , Neoplasias/genética , Transcriptoma , Hibridación Genómica Comparativa , Perfilación de la Expresión Génica , Redes Reguladoras de Genes , Sitios Genéticos , Humanos , ARN Mensajero/genética , ARN Neoplásico/genética
3.
PLoS One ; 8(11): e78665, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24260124

RESUMEN

MOTIVATION: Weighted semantic networks built from text-mined literature can be used to retrieve known protein-protein or gene-disease associations, and have been shown to anticipate associations years before they are explicitly stated in the literature. Our text-mining system recognizes over 640,000 biomedical concepts: some are specific (i.e., names of genes or proteins) others generic (e.g., 'Homo sapiens'). Generic concepts may play important roles in automated information retrieval, extraction, and inference but may also result in concept overload and confound retrieval and reasoning with low-relevance or even spurious links. Here, we attempted to optimize the retrieval performance for protein-protein interactions (PPI) by filtering generic concepts (node filtering) or links to generic concepts (edge filtering) from a weighted semantic network. First, we defined metrics based on network properties that quantify the specificity of concepts. Then using these metrics, we systematically filtered generic information from the network while monitoring retrieval performance of known protein-protein interactions. We also systematically filtered specific information from the network (inverse filtering), and assessed the retrieval performance of networks composed of generic information alone. RESULTS: Filtering generic or specific information induced a two-phase response in retrieval performance: initially the effects of filtering were minimal but beyond a critical threshold network performance suddenly drops. Contrary to expectations, networks composed exclusively of generic information demonstrated retrieval performance comparable to unfiltered networks that also contain specific concepts. Furthermore, an analysis using individual generic concepts demonstrated that they can effectively support the retrieval of known protein-protein interactions. For instance the concept "binding" is indicative for PPI retrieval and the concept "mutation abnormality" is indicative for gene-disease associations. CONCLUSION: Generic concepts are important for information retrieval and cannot be removed from semantic networks without negative impact on retrieval performance.


Asunto(s)
Minería de Datos/métodos , Semántica , Vocabulario Controlado , Humanos
4.
Proteomics ; 12(4-5): 543-9, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22246801

RESUMEN

Bioinformatics is the field where computational methods from various domains have come together for analysis of biological data. Each domain has introduced its own specific jargon. However, in closely related domains, e.g. machine learning and statistics, concordant and discordant terminology occurs, the later can lead to confusion. This article aims to help solve the confusion of tongues arising from these two closely related domains, which are frequently used in bioinformatics. We provide a short summary of the most commonly applied machine learning and statistical approaches to data analysis in bioinformatics, i.e. classification and statistical hypothesis testing. We explain differences and similarities in common terminology used in various domains, such as precision, recall, sensitivity and true positive rate. This primer can serve as a guide to the terminology used in these fields.


Asunto(s)
Inteligencia Artificial , Biología Computacional/métodos , Proteómica/métodos , Estadística como Asunto/métodos , Modelos Estadísticos
5.
Proteomics ; 11(5): 843-53, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21280221

RESUMEN

We introduce a framework for predicting novel protein-protein interactions (PPIs), based on Fisher's method for combining probabilities of predictions that are based on different data sources, such as the biomedical literature, protein domain and mRNA expression information. Our method compares favorably to our previous method based on text-mining alone and other methods such as STRING. We evaluated our algorithms through the prediction of experimentally found protein interactions underlying Muscular Dystrophy, Huntington's Disease and Polycystic Kidney Disease, which had not yet been recorded in protein-protein interaction databases. We found a 1.74-fold increase in the mean average prediction precision for dysferlin and a 3.09-fold for huntingtin when compared to STRING. The top 10 of predicted interaction partners of huntingtin were analysed in depth. Five were identified previously, and the other five were new potential interaction partners. The full matrix of human protein pairs and their prediction scores are available for download. Our framework can be extended to predict other types of relationships such as proteins in a complex, pathway or related disease mechanisms.


Asunto(s)
Enfermedad de Huntington/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas Musculares/metabolismo , Distrofias Musculares/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Proteínas Nucleares/metabolismo , Enfermedades Renales Poliquísticas/metabolismo , Mapeo de Interacción de Proteínas/métodos , Algoritmos , Animales , Biología Computacional/métodos , Bases de Datos de Proteínas , Drosophila , Disferlina , Expresión Génica , Humanos , Proteína Huntingtina , Enfermedad de Huntington/genética , Proteínas de la Membrana/genética , Ratones , Terapia Molecular Dirigida , Proteínas Musculares/genética , Distrofias Musculares/genética , Proteínas del Tejido Nervioso/genética , Proteínas Nucleares/genética , Enfermedades Renales Poliquísticas/genética , Valor Predictivo de las Pruebas , Probabilidad , Unión Proteica , Estructura Terciaria de Proteína , ARN Mensajero
6.
PLoS One ; 5(11): e13854, 2010 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-21079765

RESUMEN

Dysferlin is critical for repair of muscle membranes after damage. Mutations in dysferlin lead to a progressive muscular dystrophy. Recent studies suggest additional roles for dysferlin. We set out to study dysferlin's protein-protein interactions to obtain comprehensive knowledge of dysferlin functionalities in a myogenic context. We developed a robust and reproducible method to isolate dysferlin protein complexes from cells and tissue. We analyzed the composition of these complexes in cultured myoblasts, myotubes and skeletal muscle tissue by mass spectrometry and subsequently inferred potential protein functions through bioinformatics analyses. Our data confirm previously reported interactions and support a function for dysferlin as a vesicle trafficking protein. In addition novel potential functionalities were uncovered, including phagocytosis and focal adhesion. Our data reveal that the dysferlin protein complex has a dynamic composition as a function of myogenic differentiation. We provide additional experimental evidence and show dysferlin localization to, and interaction with the focal adhesion protein vinculin at the sarcolemma. Finally, our studies reveal evidence for cross-talk between dysferlin and its protein family member myoferlin. Together our analyses show that dysferlin is not only a membrane repair protein but also important for muscle membrane maintenance and integrity.


Asunto(s)
Proteínas de la Membrana/metabolismo , Mapeo de Interacción de Proteínas/métodos , Proteoma/metabolismo , Proteómica/métodos , Sarcolema/metabolismo , Animales , Western Blotting , Células Cultivadas , Análisis por Conglomerados , Disferlina , Perfilación de la Expresión Génica , Inmunoprecipitación , Proteínas de la Membrana/genética , Ratones , Fibras Musculares Esqueléticas/metabolismo , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Mioblastos/citología , Mioblastos/metabolismo , Unión Proteica , Proteoma/genética , Espectrometría de Masa por Ionización de Electrospray
7.
PLoS One ; 5(8): e11940, 2010 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-20694146

RESUMEN

Calpain 3 (CAPN3) is a cysteine protease that when mutated causes Limb Girdle Muscular Dystrophy 2A. It is thereby the only described Calpain family member that genetically causes a disease. Due to its inherent instability little is known of its substrates or its mechanism of activity and pathogenicity. In this investigation we define a primary sequence motif underlying CAPN3 substrate cleavage. This motif can transform non-related proteins into substrates, and identifies >300 new putative CAPN3 targets. Bioinformatic analyses of these targets demonstrate a critical role in muscle cytoskeletal remodeling and identify novel CAPN3 functions. Among the new CAPN3 substrates are three E3 SUMO ligases of the Protein Inhibitor of Activated Stats (PIAS) family. CAPN3 can cleave PIAS proteins and negatively regulates PIAS3 sumoylase activity. Consequently, SUMO2 is deregulated in patient muscle tissue. Our study thus uncovers unexpected crosstalk between CAPN3 proteolysis and protein sumoylation, with strong implications for muscle remodeling.


Asunto(s)
Calpaína/metabolismo , Biología Computacional , Músculos/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Calpaína/química , Secuencia de Consenso , Citoesqueleto/metabolismo , Humanos , Cinética , Datos de Secuencia Molecular , Músculos/citología
8.
PLoS One ; 4(11): e7894, 2009 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-19924298

RESUMEN

We have developed a method that predicts Protein-Protein Interactions (PPIs) based on the similarity of the context in which proteins appear in literature. This method outperforms previously developed PPI prediction algorithms that rely on the conjunction of two protein names in MEDLINE abstracts. We show significant increases in coverage (76% versus 32%) and sensitivity (66% versus 41% at a specificity of 95%) for the prediction of PPIs currently archived in 6 PPI databases. A retrospective analysis shows that PPIs can efficiently be predicted before they enter PPI databases and before their interaction is explicitly described in the literature. The practical value of the method for discovery of novel PPIs is illustrated by the experimental confirmation of the inferred physical interaction between CAPN3 and PARVB, which was based on frequent co-occurrence of both proteins with concepts like Z-disc, dysferlin, and alpha-actinin. The relationships between proteins predicted by our method are broader than PPIs, and include proteins in the same complex or pathway. Dependent on the type of relationships deemed useful, the precision of our method can be as high as 90%. The full set of predicted interactions is available in a downloadable matrix and through the webtool Nermal, which lists the most likely interaction partners for a given protein. Our framework can be used for prioritizing potential interaction partners, hitherto undiscovered, for follow-up studies and to aid the generation of accurate protein interaction maps.


Asunto(s)
Biología Computacional/métodos , Mapeo de Interacción de Proteínas/métodos , Proteínas/química , Algoritmos , Animales , Calpaína/metabolismo , Clonación Molecular , Humanos , MEDLINE , Ratones , Modelos Estadísticos , Proteínas Musculares/metabolismo , Unión Proteica , Proteínas/metabolismo , Curva ROC , Proteínas Recombinantes/química , Reproducibilidad de los Resultados , Estados Unidos
9.
Am J Cardiol ; 97(4): 462-5, 2006 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-16461037

RESUMEN

Dobutamine stress echocardiography (DSE) has a modest sensitivity for detecting single-vessel coronary artery disease (CAD). This study assessed the additional diagnostic value of new or worsening wall motion abnormalities during recovery after acute administration of beta blockers. The study population consisted of 200 patients (mean 59 +/- 11 years of age, 144 men), who underwent DSE. Images were acquired at rest, low dose, peak dose, and during recovery. Patients received intravenous metoprolol (1 to 5 mg/min). The dose was adjusted to achieve a recovery heart rate within a 10% range of heart rate at rest. Coronary angiography was performed within 2 months. Inducible new wall motion abnormalities were observed in 168 patients (84%) at peak stress. An additional 14 patients (7%) developed new or worsening wall motion abnormalities during recovery. CAD was detected in 182 patients (86 had single-vessel CAD). Sensitivity, specificity, and accuracy of DSE were 88%, 65%, and 73% at peak stress and 97%, 65%, and 74% during recovery. Sensitivity was particularly higher during recovery than during peak stress in patients with single-vessel CAD (98% vs 81%, p <0.001). In conclusion, assessment of wall motion abnormalities during the recovery phase after acute beta blockade improves sensitivity of DSE, particularly in patients with single-vessel CAD.


Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Enfermedad Coronaria/fisiopatología , Ecocardiografía de Estrés , Metoprolol/farmacología , Antagonistas Adrenérgicos beta/administración & dosificación , Angiografía Coronaria , Dobutamina , Femenino , Humanos , Masculino , Metoprolol/administración & dosificación , Persona de Mediana Edad , Sensibilidad y Especificidad
10.
J Med Chem ; 34(3): 1082-5, 1991 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2002450

RESUMEN

We have found that (R,S)-1-(phenylthio)-aminopropane (4a), a synthetic alternate substrate for the terminal enzyme of norepinephrine biosynthesis, dopamine beta-monooxygenase (DBM), is both an indirect sympathomimetic and a potent antihypertensive agent in spontaneously hypertensive rats. We demonstrate herein that there is a distinct enantiospecific difference in the activities of (R)-1-(phenylthio)-2-aminopropane (4b) and (S)-1-(phenylthio)-2-aminopropane (4c). We find that 4c, the more potent DBM substrate analogue, exhibits both the indirect sympathomimetic activity and the antihypertensive activity previously observed for the racemate and inhibits the active transport of catecholamines at the nerve terminal. In contrast, 4b, which is less potent as a DBM substrate or as an inhibitor of catecholamine uptake, does not exhibit an indirect sympathomimetic effect and is not an effective antihypertensive agent. These results suggest that the greater selectivity of the S enantiomer for both the catecholamine reuptake transporter and the target enzyme DBM accounts for its greater potency as an indirect-acting sympathomimetic agent as well as its activity as an antihypertensive agent. These results are also consistent with the hypothesized mechanism of action of this class of sulfur-containing DBM substrate analogues.


Asunto(s)
Antihipertensivos/uso terapéutico , Dopamina beta-Hidroxilasa/metabolismo , Hipertensión/tratamiento farmacológico , Propilaminas/uso terapéutico , Sulfuros/uso terapéutico , Animales , Antihipertensivos/síntesis química , Antihipertensivos/metabolismo , Fenómenos Químicos , Química , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Cinética , Masculino , Propilaminas/síntesis química , Propilaminas/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas , Ratas Endogámicas WKY , Estereoisomerismo , Relación Estructura-Actividad , Sulfuros/síntesis química , Sulfuros/metabolismo , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo
11.
Anal Biochem ; 178(1): 177-83, 1989 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2729571

RESUMEN

A chiral derivatizing reagent, N-succinimidyl-2-(S)-methoxy-2-phenylacetic acid ester (SMPA), directed toward reaction with primary amine-containing compounds has been synthesized and characterized. This reagent is suitable for HPLC resolution from enzymatic-scale reactions where only microgram quantities of chiral products may be obtainable. SMPA derivatization was shown to be effective in the resolution of the enantiomers of a number of different racemic compounds. SMPA was used to resolve the diastereoisomeric derivatives of a previously unknown enzymatically oxygenated product, allowing determination of the stereochemical course of the enzymatic reaction. SMPA is easily prepared from an inexpensive, commercially available, and enantiomerically pure precursor with the formation of a shelf-stable crystalline product which is utilizable in water-containing solutions. In addition to its usefulness for micro-determinations, SMPA is useful for preparative-scale resolutions of enantiomers since the reagent is cleaved from the diastereoisomeric derivative by acid hydrolysis.


Asunto(s)
Aminas/metabolismo , Fenilacetatos/síntesis química , Succinimidas/síntesis química , Cromatografía Líquida de Alta Presión , Fenilacetatos/análisis , Estereoisomerismo , Succinimidas/análisis
12.
J Biol Chem ; 264(1): 124-30, 1989 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-2909510

RESUMEN

Chromaffin granule ghosts from bovine adrenal medullae have been used to investigate the effects of prototypic dopamine beta-monooxygenase substrate analogs of two distinct classes on intravesicular reduced ascorbic acid (AscH2) levels and on norepinephrine synthesis. Phenyl-2-aminoethyl sulfide (PAES), a sulfur-containing substrate, was shown to concentrate within ghosts, a process that was time and ATP dependent, but reserpine insensitive. Dopamine beta-monooxygenase oxygenation of PAES resulted in accumulation of the oxygenation product, PAESO, without affecting intravesicular levels of AscH2. Similarly, incubations of ghosts with phenyl-2-aminoethyl selenide (PAESe) also resulted in rapid, time- and ATP-dependent, but reserpine-insensitive uptake. However, oxygenation of PAESe by dopamine beta-monooxygenase within ghosts was found to cause a marked decrease in intravesicular AscH2, without buildup of the oxygenated product, phenyl 2-aminoethyl selenoxide. These results illustrate two basic differences between the consequences of PAES and PAESe turnover: while PAES accumulation proceeds concomitant with PAESO production and without AscH2 depletion, PAESe accumulation proceeds with a marked lowering of internal AscH2 but without observable product formation. Both PAES and PAESe were capable of competing with dopamine, the physiological substrate, for enzymatic oxygenation and/or vesicular uptake, and were capable of significantly reducing norepinephrine synthesis. In experiments where ghosts were preincubated with either PAES or PAESe with delayed addition of dopamine, it was clear that neither compound nor their oxygenated products interfered with electron transport via cytochrome b561. These results are consistent with the hypothesis that the physiological activity observed with both PAES and PAESe may be related to their ability to gain entrance to adrenergic neurons and decrease norepinephrine synthesis within neurotransmitter storage vesicles.


Asunto(s)
Ácido Ascórbico/metabolismo , Gránulos Cromafines/metabolismo , Sistema Cromafín/metabolismo , Dopamina beta-Hidroxilasa/metabolismo , Etilaminas/farmacología , Membranas Intracelulares/metabolismo , Norepinefrina/biosíntesis , Compuestos de Organoselenio , Óxidos/farmacología , Fenetilaminas/metabolismo , Fenetilaminas/farmacología , Médula Suprarrenal/metabolismo , Animales , Bovinos , Gránulos Cromafines/efectos de los fármacos , Etilaminas/metabolismo , Membranas Intracelulares/efectos de los fármacos , Óxidos/metabolismo
13.
Arch Int Pharmacodyn Ther ; 296: 76-86, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3240025

RESUMEN

In earlier work we have demonstrated that a novel series of phenylethylamine analogs (phenyl-2-aminoethyl sulfides) cause a potent antihypertensive effect in spontaneously hypertensive rats. In addition, we have shown in vitro that these compounds are facile substrates for dopamine beta-hydroxylase, the terminal enzyme of norepinephrine synthesis. While the mechanism of action of these derivatives is as yet hypothetical, we have proposed that, if they are capable of gaining entrance into adrenergic nerve endings and neurotransmitter storage vesicles, these compounds may reduce norepinephrine synthesis by competing with dopamine for oxygenation. In this report, we present results of preliminary studies designed to examine this hypothetical mechanism of action. We find that all derivatives of this series are classical indirect-acting sympathomimetics whose initial cardiovascular activity is blocked by cocaine. These results suggest that compounds of this type gain entrance to adrenergic neurons via the normal norepinephrine uptake mechanism on adrenergic nerve endings. We also present data which demonstrate that the methylated derivative was not only the most potent indirect-acting sympathomimetic, but also the only derivative capable of producing a marked tachyphylaxis. In addition, we find these compounds affect a specific pool of intraneuronal norepinephrine, distinct from that affected by tyramine, a well-known indirect-acting sympathomimetic agent.


Asunto(s)
Fenetilaminas/metabolismo , Sulfuros/metabolismo , Sistema Nervioso Simpático/metabolismo , Anestesia , Animales , Presión Sanguínea/efectos de los fármacos , Cocaína/farmacología , Perros , Relación Dosis-Respuesta a Droga , Norepinefrina/farmacología , Taquifilaxis/efectos de los fármacos , Tiramina/farmacología
14.
J Pharmacol Exp Ther ; 246(1): 227-34, 1988 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-3392654

RESUMEN

The effect of phenyl-2-aminoethyl selenide (PAESe) on blood pressure and heart rate was examined in anesthetized dogs and spontaneously hypertensive rats (SHR) in order to assess its possible utility as an antihypertensive agent. PAESe was shown to be an indirect-acting sympathomimetic whose transient increase in blood pressure was blocked by cocaine. PAESe exhibited potent antihypertensive activity in SHR. This hypotensive activity was dose-dependent, was evident in both acute and chronic assays and occurred after i.v. or i.p. administration or slow release from subdermally implanted osmotic pumps. The hypotensive activity in SHR occurred concomitant with a reduction in heart rate and a reduction in total body weight. Hearts isolated from SHR treated daily for 2 weeks with PAESe were significantly reduced in weight and in total catecholamine content. An investigation of the nature of the body weight loss which accompanied chronic dosing suggested that PAESe also possessed an anorexigenic property distinct from its antihypertensive activity. An examination of plasma electrolytes, enzymes and other metabolites from chronically treated rats showed no obvious toxic effects of such dosing.


Asunto(s)
Antihipertensivos/uso terapéutico , Etilaminas/uso terapéutico , Compuestos de Organoselenio , Simpatomiméticos/uso terapéutico , Animales , Presión Sanguínea/efectos de los fármacos , Perros , Electrólitos/sangre , Frecuencia Cardíaca/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Ratas , Ratas Endogámicas SHR
16.
J Cardiovasc Pharmacol ; 11(5): 501-10, 1988 May.
Artículo en Inglés | MEDLINE | ID: mdl-2455835

RESUMEN

In previous work we established that phenyl-2-aminoethyl sulfide (PAES) and derivatives of this basic structure are novel substrate analogs for the adrenergic synthetic enzyme, dopamine beta-monooxygenase (DBM). We examined the in vivo effects of infusions of PAES and ring-hydroxylated (HOPAES) and/or alpha-methylated derivatives (MePAES, HOMePAES) and observed antihypertensive activity in SHR with HOPAES and HOMePAES using an indirect blood pressure measuring protocol. We now wish to report that by employing a direct blood pressure measuring technique we have been able to demonstrate a potent antihypertensive activity of all these derivatives in conscious, unrestrained spontaneously hypertensive rats (SHR) that persisted beyond a 6-h testing period. We found that MePAES, which displayed only a minor antihypertensive activity in the indirect measurements, was the most potent antihypertensive in the direct measuring protocol. In addition, in this report we demonstrate a potent chronic antihypertensive effect for MePAES over a 2-week period in SHR using continuous infusion with implanted osmotic pumps. From a comparison of the effects of the hydroxylated and alpha-methylated derivatives, we conclude that: (a) the locus of the antihypertensive activity is primarily in peripheral adrenergic sites; (b) alpha-methylation of the basic structure imparts an increased affinity for peripheral adrenergic uptake sites that may be responsible for its increased antihypertensive potency; and (c) monoamine oxidase (MAO) catabolism plays a relatively unimportant role in the termination of the activity of these compounds. These results also demonstrate the importance of direct blood pressure measurements in assaying antihypertensive activity of test compounds that possess indirect sympathomimetic activity. The implications of these findings in terms of the mechanism by which these compounds exert their anti-hypertensive activity is discussed.


Asunto(s)
Antihipertensivos/farmacología , Etilaminas/farmacología , Anestesia , Animales , Presión Sanguínea/efectos de los fármacos , Cocaína/farmacología , Perros , Tolerancia a Medicamentos , Masculino , Ratas , Ratas Endogámicas SHR , Simpatomiméticos , Factores de Tiempo
17.
J Biol Chem ; 263(2): 666-72, 1988 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-3335518

RESUMEN

Chromaffin granule ghosts from bovine adrenal medullae have been used to examine the ability of membrane-bound dopamine beta-monooxygenase to interact directly with intravesicular ascorbate and to investigate vectorial electron transfer from external ascorbate across the ghost membrane. Ghosts prepared by a modification of published procedures were shown to be fully active in both dopamine uptake and norepinephrine production. Dopamine uptake is dependent on the presence of a magnesium and ATP ionic complex, is abolished by reserpine, and reaches a steady-state level in the presence of dopamine beta-monooxygenase, ascorbate, catalase, and fumarate. Omission of ascorbate either inside or outside the ghosts greatly enhances dopamine accumulation, which reaches levels of approximately 30 nmol/mg under these conditions. Correspondingly, in the presence of all components, norepinephrine production reached approximately 100 nmol/mg in 30 min of incubation. Norepinephrine production was strictly magnesium-ATP-dependent, inhibited by either reserpine or dopamine beta-monooxygenase inactivation, and was markedly reduced when ascorbate was omitted from either inside or outside the ghosts. In the presence of limiting amounts of internal ascorbate, rapid norepinephrine production occurred which corresponded to the amount of initial ascorbate present, followed by a much slower endogenous norepinephrine production observable after complete depletion of internal ascorbate. The endogenous rate of norepinephrine production likely represents epinephrine-supported dopamine beta-monooxygenase turnover. Taken together, the data demonstrate that facile norepinephrine production by membrane-bound dopamine beta-monooxygenase occurs only when internal ascorbate is present, terminates upon depletion of internal ascorbate, and can only be sustained at a significant rate when reducing equivalents from external ascorbate are available.


Asunto(s)
Ácido Ascórbico/metabolismo , Gránulos Cromafines/enzimología , Sistema Cromafín/enzimología , Dopamina beta-Hidroxilasa/metabolismo , Médula Suprarrenal/ultraestructura , Animales , Bovinos , Cromatografía Líquida de Alta Presión , Dopamina/metabolismo , Epinefrina/metabolismo , Membranas/enzimología , Norepinefrina/metabolismo , Factores de Tiempo
18.
Biochemistry ; 26(6): 1626-33, 1987 Mar 24.
Artículo en Inglés | MEDLINE | ID: mdl-3036204

RESUMEN

The competence of dopamine beta-monooxygenase (DBM) to process selenide substrates was investigated, in anticipation that the expected selenoxide products would exhibit unique reactivity and redox properties. The prototypical selenide phenyl 2-aminoethyl selenide (PAESe) was synthesized and shown to be a substrate for DBM with the characteristic e/O2 ratio of 2:1 for monooxygenation. The kinetic parameters for oxygenation of PAESe were found to be similar to those for the DBM-catalyzed sulfoxidation of the cognate sulfide phenyl 2-aminoethyl sulfide [May, S. W., & Phillips, R. S. (1980) J. Am. Chem. Soc. 102, 5981-5983], and selenoxidation was stimulated by fumarate in a manner similar to other well-characterized DBM monooxygenation reactions. Identification of phenyl 2-aminoethyl selenoxide (PAESeO) as the enzymatic product was accomplished by the demonstration of coincident elution of authentic PAESeO with the enzymatic product in three significantly different HPLC systems. PAESeO was found to oxidize ascorbic acid with the concomitant and stoichiometric reduction of PAESeO back to the selenide, PAESe. As a consequence of this nonenzymatic reaction, ascorbate-supported DBM turnover was prematurely terminated under standard assay conditions due to depletion of reduced ascorbate. The kinetics of the redox reaction between PAESeO and ascorbate were investigated with a spectrophotometric assay of ascorbate at 300 nm, and a second-order rate constant of 3.4 M-1 s-1 was determined at pH 5.0, 25 degrees C. Spectrophotometric assay of cytochrome c (cyt c) reduction at 550 nm during the oxidation of ascorbate by PAESeO demonstrated that no cyt c trappable semidehydroascorbate was produced in this nonenzymatic reaction.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Ácido Ascórbico/metabolismo , Dopamina beta-Hidroxilasa/metabolismo , Compuestos de Organoselenio , Óxidos/metabolismo , Fenetilaminas/metabolismo , Selenio/metabolismo , Glándulas Suprarrenales/enzimología , Animales , Bovinos , Grupo Citocromo c/metabolismo , Indicadores y Reactivos , Cinética , Oxidación-Reducción , Óxidos/síntesis química , Fenetilaminas/síntesis química
19.
Biochem J ; 242(1): 227-33, 1987 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-3593236

RESUMEN

The interaction of dopamine beta-mono-oxygenase (DBM) with substrate analogues possessing either imidazole or pyrazole functionalities at the alkyl chain terminus was investigated. 1-(4-Hydroxybenzyl)imidazole (4-HOBI) is an active substrate for DBM, and it exhibits the expected ascorbate- and fumarate-dependencies and normal kinetic behaviour at concentrations up to 10 mM. 4-Hydroxybenzaldehyde was identified as the product formed from 4-HOBI on the basis of h.p.l.c. and g.c.-m.s. analysis, and its formation exhibits the expected 1:1 stoichiometry with O2 consumption. The 4-HOBI/DBM reaction is kinetically comparable with other DBM activities, and 4-HOBI is the first substrate analogue yet reported that exhibits substantial activity though lacking a terminal amino group. Introduction of a methyl substituent at the 2-position of the imidazole ring abolishes substrate activity, probably through a steric effect. 1-(4-Hydroxybenzyl)pyrazole, where imidazole is replaced by the isomeric pyrazole moiety, is a potent DBM inhibitor, and not a substrate. These results represent the first report of an active heterocyclic substrate or inhibitor for this enzyme, and establish the basis for the design of new classes of DBM substrates and inhibitors.


Asunto(s)
Dopamina beta-Hidroxilasa/metabolismo , Imidazoles/metabolismo , Pirazoles/metabolismo , Catálisis , Cromatografía Líquida de Alta Presión , Dopamina beta-Hidroxilasa/antagonistas & inhibidores , Cromatografía de Gases y Espectrometría de Masas , Imidazoles/farmacología , Cinética , Oxígeno/metabolismo , Pirazoles/farmacología , Especificidad por Sustrato
20.
Biochemistry ; 24(21): 5826-39, 1985 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-4084493

RESUMEN

In an initial communication [May, S. W., Mueller, P. W., Padgette, S. R., Herman, H. H., & Phillips, R. S. (1983) Biochem. Biophys. Res. Commun. 110, 161-168], we reported that 1-phenyl-1-(aminomethyl)ethene hydrochloride (PAME) is an olefinic substrate for dopamine beta-monooxygenase (DBM; EC 1.14.17.1) which inactivates the enzyme in an apparent mechanism-based manner. The present study further characterizes this reaction. The inactivation reaction yields kinact = 0.23 min-1 at pH 5.0 and 37 degrees C and is strictly dependent on reductant (ascorbate) and oxygen. The DBM/PAME substrate reaction (apparent kcat = 14 s-1), shown to be stimulated by fumarate, gives the corresponding epoxide as product, identified by derivatization with 4-(p-nitrobenzyl)pyridine. However, the lack of DBM inhibition by alpha-methylstyrene oxide, and the observation of identical PAME/DBM inactivation rates in the absence and presence of preformed enzymatic PAME epoxide, indicates that free epoxide is not the inactivating species. A structure-activity study revealed that 4-hydroxylation of PAME (to give 4-HOPAME) increases both kinact (0.81 min-1) and apparent kcat (56 s-1) values, while 3-hydroxylation (to give 3-HOPAME) greatly diminishes inactivation activity while retaining substrate activity (apparent kcat = 47 s-1). 4-Hydroxy-alpha-methylstyrene was found to be a DBM inhibitor (kinact = 0.53 min-1) with weak substrate activity (apparent kcat = 0.71 s-1), while 3-hydroxy-alpha-methylstyrene and alpha-(cyanomethyl) styrene were found not to exhibit detectable DBM substrate activity and only weak inhibitory activity. 3-Phenylpropargylamine hydrochloride showed no detectable DBM substrate activity but rapidly inactivated the enzyme. A new substrate activity for DBM was discovered, N-dealkylation of N-phenylethylenediamine and N-methyl-N-phenylethylenediamine, and the lack of O-dealkylation activity with phenyl 2-aminoethyl ether and 4-hydroxyphenyl 2-aminoethyl ether indicates that DBM N-dealkylation proceeds via initial one-electron abstraction from the benzylic nitrogen heteroatom. With this new substrate and inhibitor reactivity information in hand, along with the other known substrate reactions, a DBM oxygenation mechanism analogous to that for cytochrome P-450 is proposed.


Asunto(s)
Alquenos/metabolismo , Dopamina beta-Hidroxilasa/metabolismo , Glándulas Suprarrenales/enzimología , Alquenos/síntesis química , Alquenos/farmacología , Animales , Bovinos , Dopamina beta-Hidroxilasa/antagonistas & inhibidores , Dopamina beta-Hidroxilasa/aislamiento & purificación , Concentración de Iones de Hidrógeno , Indicadores y Reactivos , Cinética , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...